Nuvo Pharmaceuticals Inc
F:23N
Nuvo Pharmaceuticals Inc
F:23N
Price:
0.9
EUR
-1.64%
Market Closed
Market Cap:
€10.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Nuvo Pharmaceuticals Inc
F:23N
|
CA |
|
P
|
Pitney Bowes Inc
F:PBW
|
US |
|
US Energy Corp
NASDAQ:USEG
|
US |
|
Naturgy Energy Group SA
F:GANA
|
ES |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
XMUN:ME9
|
IT |
|
O
|
Okinawa Cellular Telephone Co
XMUN:OCU
|
JP |
|
C
|
Campbell Soup Co
XMUN:CSC
|
US |
|
F
|
Flex Ltd
F:FXI
|
SG |
|
H
|
Home Product Center PCL
SET:HMPRO
|
TH |
|
O
|
Oracle Corp
XHAM:ORC
|
US |
|
C
|
Crest Nicholson Holdings PLC
F:C38
|
UK |
|
I
|
International Paper Co
F:INP
|
US |
|
F
|
Fairfax Financial Holdings Ltd
SWB:FFX
|
CA |
|
C
|
Central Garden & Pet Co
NASDAQ:CENTA
|
US |
|
Inpixon
NASDAQ:XTIA
|
US |
|
C
|
China Industrial Group Inc
OTC:CIND
|
US |
|
Greenyard NV
F:2P1
|
BE |
|
O
|
Old Dominion Freight Line Inc
F:ODF
|
US |
|
Eton Pharmaceuticals Inc
NASDAQ:ETON
|
US |
|
B
|
BHP Group Ltd
XMUN:BHP
|
AU |
|
W
|
Woolworths Group Ltd
XMUN:WWR
|
AU |
|
B
|
BRP Inc
NASDAQ:DOOO
|
CA |
|
C
|
Cintas Corp
DUS:CIT
|
US |
|
B
|
Build-A-Bear Workshop Inc
F:FPW
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 23N's stock price target?
Not Available
23N does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Nuvo Pharmaceuticals Inc?
Projected CAGR
5%
5%
Over the last 8 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 2 years is 5%.
What is the Operating Income forecast for Nuvo Pharmaceuticals Inc?
Projected CAGR
-26%
-26%
The compound annual growth rate for Operating Income over the next 4 years is -26%.
